New NIH Grant: Accelerated Biological Aging and Immunosenescence as Drivers for Racial Disparities in Monoclonal Ga — $558K at Unknown Institution
WHY IT MATTERS
This research directly addresses why African American patients develop multiple myeloma at higher rates, which could lead to earlier screening and better prevention strategies for this high-risk population.
Researchers are studying why multiple myeloma and a related blood condition called MGUS are more common in African American patients. Scientists received $558,000 to investigate whether faster aging of the immune system might explain these differences. Interestingly, when African American patients get equal healthcare access, they actually do better than other groups, which suggests biology and healthcare access both play a role.
Project: Accelerated Biological Aging and Immunosenescence as Drivers for Racial Disparities in Monoclonal Gammopathy of Undetermined Significance (MGUS) PI: BAUGHN, LINDA B Institution: Unknown Institution Funding: $558K Start Date: 2026-05-08 Abstract: PROJECT SUMMARY Multiple myeloma (MM) is an incurable plasma cell malignancy and the most common blood cancer among individuals who self-identify as African American, accounting for ~20% of newly diagnosed cases. The biological factors contributing to the increased risk of MM and its precursor condition, monoclonal gammopathy of undetermined significance (MGUS), in individuals of African ancestry remain poorly understood. Strikingly, when access to healthcare is equal, African American patients experience better clinical outcomes, and their MM tumors exhibit lower genomic complexity compared t